Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2012-12-14 |
| Study Made Public: | 2013-07-25 |
Title
Shattock_Rabbit gp140 immunogenicity_PE_401 Study
Description
CAVD 401 is a preclinical rabbit study comparing CN54gp140 DNA and protein regimens administered via intramuscular, intradermal, and subcutaneous routes.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.